Published on
September 4, 2025
- 13:15 GMT
Release Therapeutics Grants Exclusive License for MVX-ONCO to Geneva University Hospital and University of Geneva
The agreement unlocks new potential for the clinical development of the legacy oncology platform, as Release Therapeutics advances its focus on CNS therapies. GENEVA, SWITZERLAND, September 4, 2025 /EINPresswire.com/ -- Release Therapeutics (“Release Tx …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
